Abel Hall LLC’s Hologic HOLX Stock Holding History

Abel Hall LLC’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,125	Closed	-$307K	–	887
2025 Q4	$307K	Buy	+4,125	New	+$301K	0.07%	320

Other funds holding HOLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Abel Hall LLC's HOLX Position: Q1 2026 in Review

Abel Hall LLC sold out of Hologic (HOLX) in Q1 2026, closing a stake of 4,125 shares — an estimated $307K sold.

Abel Hall LLC first reported a position in HOLX in Q4 2025 and held it in 1 quarter. The position peaked at $307K in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

Abel Hall LLC reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 4,125 Hologic shares in Q1 2026, an estimated $307K.
Abel Hall LLC first reported a position in Hologic in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Hologic position peaked at $307K in Q4 2025.
704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.